GlaxoSmithKline plc (LON:GSK) had its target price hoisted by Beaufort Securities from GBX 1,750 ($22.61) to GBX 2,000 ($25.84) in a research note published on Thursday morning. They currently have a buy rating on the stock.
A number of other brokerages have also recently weighed in on GSK. Berenberg Bank lifted their target price on GlaxoSmithKline plc from GBX 1,850 ($23.90) to GBX 1,890 ($24.42) and gave the company a hold rating in a report on Friday, March 17th. HSBC Holdings plc reiterated a buy rating and issued a GBX 1,970 ($25.46) target price on shares of GlaxoSmithKline plc in a report on Wednesday, March 15th. JPMorgan Chase & Co. reiterated a neutral rating and issued a GBX 1,670 ($21.58) target price on shares of GlaxoSmithKline plc in a report on Tuesday, March 21st. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline plc in a report on Tuesday, March 7th. Finally, BNP Paribas reiterated an underperform rating and issued a GBX 1,520 ($19.64) target price on shares of GlaxoSmithKline plc in a report on Wednesday, March 22nd. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average target price of GBX 1,751.77 ($22.64).
Shares of GlaxoSmithKline plc (LON GSK) opened at 1699.00 on Thursday. The company has a 50 day moving average price of GBX 1,622.24 and a 200 day moving average price of GBX 1,594.46. GlaxoSmithKline plc has a 12-month low of GBX 1,363.00 and a 12-month high of GBX 1,745.56. The stock’s market cap is GBX 83.01 billion.
The firm also recently announced a dividend, which will be paid on Thursday, July 13th. Stockholders of record on Thursday, May 11th will be given a dividend of GBX 19 ($0.25) per share. This represents a dividend yield of 1.21%. The ex-dividend date of this dividend is Thursday, May 11th.
In other news, insider Vivienne Cox acquired 335 shares of the stock in a transaction that occurred on Wednesday, April 26th. The stock was purchased at an average cost of GBX 1,583 ($20.45) per share, with a total value of £5,303.05 ($6,852.37). Also, insider Dominic Redfern acquired 230 shares of the stock in a transaction that occurred on Thursday, April 13th. The stock was purchased at an average cost of GBX 1,639 ($21.18) per share, with a total value of £3,769.70 ($4,871.04). Over the last ninety days, insiders have bought 662 shares of company stock worth $1,066,992. GlaxoSmithKline plc Company Profile